Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferrin receptor 2 gene
- PMID: 11984516
- DOI: 10.1053/gast.2002.32984
Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferrin receptor 2 gene
Abstract
Background & aims: Although most patients with hereditary hemochromatosis are homozygous for a single mutation of the HFE gene on chromosome 6p, accumulating evidence indicates that the disease is genetically heterogeneous. Type 3 hemochromatosis, recently described in 4 families, is linked to mutations of the gene encoding transferrin receptor 2 on chromosome 7q22. Here we report data from a family carrying a new mutation of the transferrin receptor 2 gene.
Methods: Detailed clinical and histopathologic documentation was available for most family members. The entire coding sequence and exon/intron boundaries of the transferrin receptor 2 gene were analyzed by direct sequencing.
Results: A 12-nucleotide deletion in exon 16, causing the loss of 4 amino acids (AVAQ 594-597 del), was detected at the homozygous state in the 3 patients with histologically proven iron overload. The deletion segregated with the disease within the family and was not found in 100 healthy controls. Some clinical and pathologic characteristics, such as low penetrance in the premenopausal woman, and early iron deposition in periportal hepatocytes resembled those of classic, HFE-related hemochromatosis.
Conclusions: Our data support the role of the transferrin receptor 2 gene in hemochromatosis type 3 as well as its critical involvement in the maintenance of iron homeostasis in humans.
Similar articles
-
Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis.Blood Cells Mol Dis. 2001 Jan-Feb;27(1):290-3. doi: 10.1006/bcmd.2001.0382. Blood Cells Mol Dis. 2001. PMID: 11358390
-
Hemochromatosis due to mutations in transferrin receptor 2.Blood Cells Mol Dis. 2002 Nov-Dec;29(3):465-70. doi: 10.1006/bcmd.2002.0585. Blood Cells Mol Dis. 2002. PMID: 12547237
-
New mutations inactivating transferrin receptor 2 in hemochromatosis type 3.Blood. 2001 May 1;97(9):2555-60. doi: 10.1182/blood.v97.9.2555. Blood. 2001. PMID: 11313241
-
Rare causes of hereditary iron overload.Semin Hematol. 2002 Oct;39(4):249-62. doi: 10.1053/shem.2002.35638. Semin Hematol. 2002. PMID: 12382200 Review.
-
Genetic hemochromatosis update.Acta Gastroenterol Belg. 2005 Jan-Mar;68(1):33-7. Acta Gastroenterol Belg. 2005. PMID: 15832585 Review.
Cited by
-
Hereditary hemochromatosis in the post-HFE era.Hepatology. 2008 Sep;48(3):991-1001. doi: 10.1002/hep.22507. Hepatology. 2008. PMID: 18752323 Free PMC article.
-
Diagnosis of juvenile hemochromatosis in an 11-year-old child combining genetic analysis and non-invasive liver iron quantitation.Eur J Pediatr. 2003 Feb;162(2):96-9. doi: 10.1007/s00431-002-1114-6. Epub 2002 Dec 10. Eur J Pediatr. 2003. PMID: 12548385
-
Heterozygous recipient and donor HFE mutations associated with a hereditary haemochromatosis phenotype after liver transplantation.Gut. 2003 Mar;52(3):433-5. doi: 10.1136/gut.52.3.433. Gut. 2003. PMID: 12584229 Free PMC article.
-
Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosis.Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10653-8. doi: 10.1073/pnas.162360699. Epub 2002 Jul 19. Proc Natl Acad Sci U S A. 2002. PMID: 12134060 Free PMC article.
-
Non-HFE hemochromatosis.Rev Bras Hematol Hemoter. 2012;34(4):311-6. doi: 10.5581/1516-8484.20120079. Rev Bras Hematol Hemoter. 2012. PMID: 23049448 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical